On October 17, the plenary session “Russian healthcare in the era of fight against the pandemic. Contribution of the Russian industry” was held as part of the V forum “BIOTECHMED-2020”.

Participants elaborated on priorities in the development of health care and measures to ensure a stable epidemiological situation in the country as well as the practical role of the industry in health care.

The session was attended by the following officials: Mikhail Albertovich Murashko (Minister of Health of the Russian Federation), Denis Valentinovich Manturov (Minister of Industry and Trade of the Russian Federation), Sergey Viktorovich Chemezov (General Director of Rostec State Corporation), Veronika Igorevna Skvortsova (Head of the Federal Medical-Biological Agency), Veniamin Ivanovich Kondratyev (governor of the Krasnodar Krai).

The session was moderated by Evelina Zakamskaya, editor-in-chief at Doctor TV channel and TV host at Russia 24.

Stanislav Naumov, Chairman of the Board of the Association of pharmaceutical manufacturers of the Eurasian Economic Union (AFPEEC), delivered one of the key messages at the session – crucial significance of vaccination as a corner stone of the national projects “Health” and “Demography”. Besides, he emphasized the following point:

“The long-term strategy “Pharma 2020” has proved to be successful. This is our collective merit and I speak on behalf of 8 pharmaceutical companies (shareholders and CEOs are present in this hall). I will give some statistics: 233 INNs, 71 billion rubles are joint investments over the past 10 years, 22 billion of them are R&D investments. And the result is: 13 thousand new jobs, of which 1,400 are scientists who work at our enterprises.”

AFPEES includes leading full-cycle pharmaceutical manufacturers: Pharmstandart PJSC, Biocad CJSC, GEROPHARM LLC, Nanolek LLC, NTFF Polisan, Active Component JSC, Generium JSC, HTC ChemRar, Nativita JV LLC, Karaganda pharmaceutical plant LLP.